Skip to content
HowShorted

Arcturus Therapeutics Holdings Inc. short interest in 2024

In 2024, Arcturus Therapeutics Holdings Inc.'s disclosed short interest ran from 15.52% of shares outstanding on 12 Jan 2024 to 17.79% on 31 Dec 2024, a change of +2.27 percentage points. The year's high was 20.17% on 15 Aug 2024 and its low 15.28% on 31 May 2024, averaging 17.24% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 17.90 days on 30 Aug 2024. Full history: Arcturus Therapeutics Holdings Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Arcturus Therapeutics Holdings Inc. in 2024

2024 in figures

Start of year
15.52% (12 Jan 2024)
End of year
17.79% (31 Dec 2024)
Change
+2.27 pp
High
20.17% (15 Aug 2024)
Low
15.28% (31 May 2024)
Average
17.24%
Highest days to cover
17.90 (30 Aug 2024)
SEC filings marked
8

Every report in 2024

Arcturus Therapeutics Holdings Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 202415.52%11.65
31 Jan 202416.35%13.69
15 Feb 202416.92%10.88
29 Feb 202415.79%9.81
15 Mar 202415.63%7.60results (8-K), 10-K filed
28 Mar 202417.87%8.25
15 Apr 202417.14%9.10
30 Apr 202418.27%11.27
15 May 202415.34%7.8310-Q filed, results (8-K)
31 May 202415.28%8.42
14 Jun 202416.28%5.90
28 Jun 202417.39%5.20
15 Jul 202419.36%8.13
31 Jul 202419.90%14.78
15 Aug 202420.17%11.7010-Q filed, results (8-K)
30 Aug 202419.90%17.90
13 Sep 202419.32%13.00
30 Sep 202417.00%11.90
15 Oct 202416.40%13.38
31 Oct 202416.94%16.77
15 Nov 202416.56%8.8910-Q filed, results (8-K)
29 Nov 202416.13%9.29
13 Dec 202416.40%12.50
31 Dec 202417.79%11.80

See also: Arcturus Therapeutics Holdings Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.